Olema Pharmaceuticals
OLMA6.4108.69% ( -0.610 )
Olema Pharmaceuticals (OLMA)
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s c...
- Open
- 6.930
- High
- 6.940
- Low
- 6.235
- Prev. Close
- 7.020
- Volume
- 1.98M
- Turnover
- 12.76M
- Avg Price
- 6.429
- Bid/Ask Ratio
- --
- Amplitude
- 10.04%
- 52wk High
- 36.259
- Volume Ratio
- 2.48
- Turnover Ratio
- 3.35%
- 52wk Low
- 6.235
- Float Mkt Cap
- 379.73M
- Market CapUSD
- 560.86M
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -2.34
- EPSDynamic
- -2.66
- EPSStatic
- --
- BVPS
- 4.92
- P/B
- 1.30
- Circulating Supply
- 59.24M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 87.50M
- Min lot size
- 1
- Currency
- USD
Olema Pharmaceuticals Analyst Rating
View moreForecast & Rating
Sep 21, 2026Price forecast
$36.50469.42%
Forecast & RatingStrong buy
12analysts
- Strong buy75.00%
- Buy16.67%
- Hold8.33%
- Sell0.00%
- Strong sell0.00%
News
- Market Movers ·
Olema Pharmaceuticals slides 8% to 52-week low
- PUBT ·
Olema Pharmaceuticals Director Gorjan Hrustanovic Resigns From Board
- benzinga_article ·
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Global Report ·
Biotech Underdogs' Equity Gambit as Wall Street Eyes Double-Digit Upside
- StockTitan ·
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | OLMA Stock News
